CD4 and neoplasm: In PDAC, IL-7 and its activation of the JAK/STAT signaling pathway may make tumor cells resistant to chemotherapeutic agents such as gemcitabine and accelerate tumor progression (131).Normally, IL-7 binding to its receptor promotes the growth and maturation of CD4+T cells by facilitating pSTAT5-NT (132).